Breaking News

Genezen Opens New Process Development and Analytical Lab

Marks a milestone for the company in launching additional early-stage capabilities needed to drive the cell and gene therapy industry forward.

Author Image

By: Charlie Sternberg

Associate Editor

Genezen Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production and analytical testing services, has opened its new process development and analytical lab.   The lab will deliver a full suite of process development capabilities to support cGMP and commercial readiness, upstream and downstream process improvements, research grade and preclinical vector production, and analytical assay development and va...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters